Zhen Su
Net worth: - $ as of 2026-09-29
Net worth: - $ as of 2026-09-29
Dr. Zhen Su is an Independent Director at CytomX Therapeutics, Inc., an Independent Director at Karyopharm Therapeutics, Inc. and a Chief Executive Officer & Director at Marengo Therapeutics, Inc. He is on the Board of Directors at CytomX Therapeutics, Inc., Karyopharm Therapeutics, Inc. and Marengo Therapeutics, Inc. Dr. Su was previously employed as a Chief Medical Officer by EMD Serono, Inc., a SVP & Global Head-Oncology Business by Merck KGaA, and a Director-Cell & Gene Therapy Program by University of Florida.
He received his MBA from the University of Toronto and a doctorate degree from Dresden University of Technology.
| Company | Date | Number of shares | Valuation | Valuation date |
|---|---|---|---|---|
| 2026-06-16 | 0 ( -.--% ) | - $ | 2026-09-29 | |
| 2026-03-29 | 0 ( -.--% ) | - $ | 2026-09-29 |
| Companies | Position | Start |
|---|---|---|
| KARYOPHARM THERAPEUTICS INC. | Director/Board Member | 2023-08-30 |
| CYTOMX THERAPEUTICS, INC. | Director/Board Member | 2024-03-20 |
Marengo Therapeutics, Inc.
Marengo Therapeutics, Inc. BiotechnologyHealth Technology Operates as a biotechnology company that develops immunotherapies for cancer treatment | Chief Executive Officer | 2021-06-30 |
| Companies | Position | End |
|---|---|---|
| MERCK KGAA | Chief Tech/Sci/R&D Officer | 2020-12-31 |
EMD Serono, Inc.
EMD Serono, Inc. BiotechnologyHealth Technology Develops therapeutics and drug delivery devices for neurology, oncology & immunology | Chief Tech/Sci/R&D Officer | 2018-12-31 |
University of Florida
University of Florida Other Consumer ServicesConsumer Services Functions as a College/University | Corporate Officer/Principal | 2008-12-31 |
Active
Inactive
Listed companies
Private companies
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
| Private companies | 8 |
|---|---|
Merck KGaA
Merck KGaA Pharmaceuticals: MajorHealth Technology Engages in the manufacturing of pharmaceutical and chemical products | Health Technology |
University of Toronto
University of Toronto Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
University of Florida
University of Florida Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
EMD Serono, Inc.
EMD Serono, Inc. BiotechnologyHealth Technology Develops therapeutics and drug delivery devices for neurology, oncology & immunology | Health Technology |
Dresden University of Technology
Dresden University of Technology Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Karyopharm Therapeutics, Inc.
Karyopharm Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Discovers and develops novel drugs for the treatment of cancer, inflammation and other diseases related to cell proliferation | Health Technology |
CytomX Therapeutics, Inc.
CytomX Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Operates as an oncology-base biopharmaceutical company, which focuses on developing probody therapeutics for the treatment of cancer | Health Technology |
Marengo Therapeutics, Inc.
Marengo Therapeutics, Inc. BiotechnologyHealth Technology Operates as a biotechnology company that develops immunotherapies for cancer treatment | Health Technology |
Select your edition
All financial news and data tailored to specific country editions